598 related articles for article (PubMed ID: 30196995)
21. Contrast-induced acute kidney injury in renal transplant recipients after cardiac catheterization.
Agrawal V; Swami A; Kosuri R; Alsabbagh M; Agarwal M; Samarapungavan D; Rocher LL; McCullough PA
Clin Nephrol; 2009 Jun; 71(6):687-96. PubMed ID: 19473638
[TBL] [Abstract][Full Text] [Related]
22. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
[TBL] [Abstract][Full Text] [Related]
23. Incidence of ventricular fibrillation during left coronary arteriography in pigs: comparison of a solution of the nonionic dimer iodixanol with solutions of five different nonionic monomers.
Chai CM; Karlsson JO; Almén T
Acta Radiol; 2008 Mar; 49(2):150-6. PubMed ID: 18300138
[TBL] [Abstract][Full Text] [Related]
24. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
[TBL] [Abstract][Full Text] [Related]
25. Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis.
Zhao F; Lei R; Yang SK; Luo M; Cheng W; Xiao YQ; Li XW; Guo J; Duan SB
Cancer Imaging; 2019 Jun; 19(1):38. PubMed ID: 31215488
[TBL] [Abstract][Full Text] [Related]
26. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
Briguori C; Colombo A; Airoldi F; Morici N; Sangiorgi GM; Violante A; Focaccio A; Montorfano M; Carlino M; Condorelli G; Ricciardelli B
Kidney Int; 2005 Nov; 68(5):2250-5. PubMed ID: 16221226
[TBL] [Abstract][Full Text] [Related]
27. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
[TBL] [Abstract][Full Text] [Related]
28. Impact of Serum Albumin Levels on Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention.
Murat SN; Kurtul A; Yarlioglues M
Angiology; 2015 Sep; 66(8):732-7. PubMed ID: 25260710
[TBL] [Abstract][Full Text] [Related]
29. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
Shin DH; Choi DJ; Youn TJ; Yoon CH; Suh JW; Kim KI; Cho YS; Cho GY; Chae IH; Kim CH
Am J Cardiol; 2011 Jul; 108(2):189-94. PubMed ID: 21545991
[TBL] [Abstract][Full Text] [Related]
30. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
[TBL] [Abstract][Full Text] [Related]
31. Low-Osmolar vs. Iso-Osmolar Contrast Media on the Risk of Contrast-Induced Acute Kidney Injury: A Propensity Score Matched Study.
Lee T; Kim WK; Kim AJ; Ro H; Chang JH; Lee HH; Chung W; Jung JY
Front Med (Lausanne); 2022; 9():862023. PubMed ID: 35572997
[TBL] [Abstract][Full Text] [Related]
32. Iodixanol-associated acute kidney injury and prognosis in patients undergoing elective percutaneous coronary intervention: a prospective, multi-center study.
Chen Z; Mao Q; Xiang L; Zhou D; Jiang Y; Zhao N; Huang L; Azzalini L; Zhao X
Eur Radiol; 2023 Dec; 33(12):9444-9454. PubMed ID: 37480548
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Adverse Effects of Low-Osmolar Compared With Iso-Osmolar Contrast Media After Coronary Angiography.
Wang YC; Tang A; Chang D; Lu CQ; Zhang SJ; Ju S
Am J Cardiol; 2016 Oct; 118(7):985-90. PubMed ID: 27521223
[TBL] [Abstract][Full Text] [Related]
34. Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Ocek AH; Celik IE; Kilic A; Koseoglu C; Oksuz F; Baris VO
Angiology; 2015 Nov; 66(10):957-63. PubMed ID: 25688117
[TBL] [Abstract][Full Text] [Related]
35. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention.
Ohno Y; Maekawa Y; Miyata H; Inoue S; Ishikawa S; Sueyoshi K; Noma S; Kawamura A; Kohsaka S; Fukuda K
J Am Coll Cardiol; 2013 Oct; 62(14):1260-1266. PubMed ID: 23770181
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular end diastolic pressure and contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Lima FV; Singh S; Parikh PB; Gruberg L
Cardiovasc Revasc Med; 2018 Sep; 19(6S):16-20. PubMed ID: 29929842
[TBL] [Abstract][Full Text] [Related]
37. Hyperuricemia Is an Independent Predictor of Contrast-Induced Acute Kidney Injury and Mortality in Patients Undergoing Percutaneous Coronary Intervention.
Guo W; Liu Y; Chen JY; Chen SQ; Li HL; Duan CY; Liu YH; Tan N
Angiology; 2015 Sep; 66(8):721-6. PubMed ID: 25616679
[TBL] [Abstract][Full Text] [Related]
38. Low free triiodothyronine is associated with contrast-induced acute kidney injury and long-term outcome in elderly patients who underwent percutaneous coronary intervention.
Lin C; Lin K; Guo Y; You Z; Zheng W; Lin F; Guo T; Zhu P
Anatol J Cardiol; 2019 Feb; 21(2):60-67. PubMed ID: 30694798
[TBL] [Abstract][Full Text] [Related]
39. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Wi J; Ko YG; Kim JS; Kim BK; Choi D; Ha JW; Hong MK; Jang Y
Heart; 2011 Nov; 97(21):1753-7. PubMed ID: 21602521
[TBL] [Abstract][Full Text] [Related]
40. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
